We are live on
!
Find out more
LSB
LakeShore Biopharma
Delisted
LSB was delisted on the 19th of September, 2025.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $344K | – | – | – |
|
2
Fidelity Investments
Boston,
Massachusetts
| $282K | – | – | – |
|
|
HA
3
HHLR Advisors
Grand Cayman,
Cayman Islands
| $182K | – | – | – |
|
|
SCM
4
Superstring Capital Management
New York
| $74.5K | – | – | – |
|
5
Barclays
London,
United Kingdom
| $60.7K | – | – | – |
|
6
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $43K | +$2.59M | +1,048,320 | New |
|
7
Citadel Advisors
Miami,
Florida
| $25.6K | +$26.2K | +10,586 | New |
|
8
UBS Group
Zurich,
Switzerland
| $2.45K | +$148 | +60 | +6% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $686 | +$693 | +280 | New |
|